Home » Topics » BioWorld Science

BioWorld Science
RSS

To escape radiation, tumor cells reversibly damage their DNA

April 29, 2022

Idorsia Pharmaceuticals patents LGALS3 inhibitors

April 29, 2022

AC-0027875, a gamma-secretase modulator for the treatment of AD

April 29, 2022

Merck & Co. presents DGAT-2 inhibitors

April 29, 2022

Dana-Farber Cancer Institute discloses new HER2 inhibitors

April 29, 2022

Vertex Pharmaceuticals patents CFTR potentiators

April 29, 2022

University of California discloses new PRMT8 inhibitors

April 29, 2022

ProfoundBio presents novel ADCs for cancer treatment

April 29, 2022

Study finds targets of T-cell response in multiple sclerosis

April 28, 2022

Allogeneic NK-cell therapy CAT-179 useful for controlling HER2-positive tumors

April 28, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.